600422 Stock Overview
A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
KPC Pharmaceuticals,Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥15.16 |
52 Week High | CN¥24.11 |
52 Week Low | CN¥14.15 |
Beta | 0.19 |
11 Month Change | -11.50% |
3 Month Change | -32.80% |
1 Year Change | -5.37% |
33 Year Change | 68.44% |
5 Year Change | 29.24% |
Change since IPO | 239.84% |
Recent News & Updates
KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jul 25Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)
Jun 25We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04Recent updates
KPC PharmaceuticalsInc (SHSE:600422) Will Pay A Larger Dividend Than Last Year At CN¥0.20
Jul 25Investors Still Waiting For A Pull Back In KPC Pharmaceuticals,Inc (SHSE:600422)
Jun 25We Think KPC PharmaceuticalsInc (SHSE:600422) Can Stay On Top Of Its Debt
Jun 04KPC PharmaceuticalsInc's (SHSE:600422) Profits May Not Reveal Underlying Issues
Mar 28Shareholder Returns
600422 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -1.8% | 0.9% | -0.3% |
1Y | -5.4% | -8.6% | -18.1% |
Return vs Industry: 600422 exceeded the CN Pharmaceuticals industry which returned -8.6% over the past year.
Return vs Market: 600422 exceeded the CN Market which returned -18.1% over the past year.
Price Volatility
600422 volatility | |
---|---|
600422 Average Weekly Movement | 5.5% |
Pharmaceuticals Industry Average Movement | 5.2% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 600422's share price has been volatile over the past 3 months.
Volatility Over Time: 600422's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1951 | 5,051 | n/a | www.kpc.com.cn |
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People’s Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections.
KPC Pharmaceuticals,Inc. Fundamentals Summary
600422 fundamental statistics | |
---|---|
Market cap | CN¥11.67b |
Earnings (TTM) | CN¥432.35m |
Revenue (TTM) | CN¥7.65b |
26.5x
P/E Ratio1.5x
P/S RatioIs 600422 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600422 income statement (TTM) | |
---|---|
Revenue | CN¥7.65b |
Cost of Revenue | CN¥4.32b |
Gross Profit | CN¥3.33b |
Other Expenses | CN¥2.90b |
Earnings | CN¥432.35m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
Earnings per share (EPS) | 0.57 |
Gross Margin | 43.54% |
Net Profit Margin | 5.65% |
Debt/Equity Ratio | 15.3% |
How did 600422 perform over the long term?
See historical performance and comparison